{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:20:45Z","timestamp":1790270445494,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["EY032181"],"award-info":[{"award-number":["EY032181"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08534-6","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:44:43Z","timestamp":1760622283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["OPTN protects retinal ganglion cells and ameliorates neuroinflammation in optic neuropathies"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3074-4786","authenticated-orcid":false,"given":"Qinglong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Da Douglas","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6685-2017","authenticated-orcid":false,"given":"Jin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengfeng","family":"Bei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9840-6732","authenticated-orcid":false,"given":"Qianbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8965-8973","authenticated-orcid":false,"given":"Feng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"8534_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25642-z","volume":"12","author":"J Ames","year":"2021","unstructured":"Ames, J. et al. OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection. Nat. Commun. 12, 5401 (2021).","journal-title":"Nat. Commun."},{"key":"8534_CR2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3389\/fimmu.2018.01024","volume":"9","author":"TA Ryan","year":"2018","unstructured":"Ryan, T. A. & Tumbarello, D. A. Optineurin: a coordinator of membrane-associated cargo trafficking and autophagy. Front. Immunol. 9, 1024 (2018).","journal-title":"Front. Immunol."},{"key":"8534_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.it.2016.07.002","volume":"37","author":"K Slowicka","year":"2016","unstructured":"Slowicka, K., Vereecke, L. & van Loo, G. Cellular functions of optineurin in health and disease. Trends Immunol. 37, 621\u2013633 (2016).","journal-title":"Trends Immunol."},{"key":"8534_CR4","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMra0804630","volume":"360","author":"YH Kwon","year":"2009","unstructured":"Kwon, Y. H., Fingert, J. H., Kuehn, M. H. & Alward, W. L. Primary open-angle glaucoma. N. Engl. J. Med 360, 1113\u20131124 (2009).","journal-title":"N. Engl. J. Med"},{"key":"8534_CR5","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1093\/hmg\/ddx184","volume":"26","author":"JL Wiggs","year":"2017","unstructured":"Wiggs, J. L. & Pasquale, L. R. Genetics of glaucoma. Hum. Mol. Genet. 26, R21\u2013R27 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"8534_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92971-w","volume":"11","author":"N Zhang","year":"2021","unstructured":"Zhang, N., Wang, J., Li, Y. & Jiang, B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci. Rep. 11, 13762 (2021).","journal-title":"Sci. Rep."},{"key":"8534_CR7","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas, J. B. et al. Glaucoma. Lancet 390, 2183\u20132193 (2017).","journal-title":"Lancet"},{"key":"8534_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1066901","volume":"295","author":"T Rezaie","year":"2002","unstructured":"Rezaie, T. et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295, 1077\u20131079 (2002).","journal-title":"Science"},{"key":"8534_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1242\/jcs.114926","volume":"126","author":"J Korac","year":"2013","unstructured":"Korac, J. et al. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 126, 580\u2013592 (2013).","journal-title":"J. Cell Sci."},{"key":"8534_CR10","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1093\/hmg\/ddv126","volume":"24","author":"V Sundaramoorthy","year":"2015","unstructured":"Sundaramoorthy, V. et al. Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis. Hum. Mol. Genet. 24, 3830\u20133846 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"8534_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1083\/jcb.200501162","volume":"169","author":"DA Sahlender","year":"2005","unstructured":"Sahlender, D. A. et al. Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J. Cell Biol. 169, 285\u2013295 (2005).","journal-title":"J. Cell Biol."},{"key":"8534_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.exer.2011.08.011","volume":"93","author":"C Sippl","year":"2011","unstructured":"Sippl, C., Bosserhoff, A. K., Fischer, D. & Tamm, E. R. Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins. Exp. Eye Res. 93, 669\u2013680 (2011).","journal-title":"Exp. Eye Res."},{"key":"8534_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-11-4","volume":"11","author":"A Nagabhushana","year":"2010","unstructured":"Nagabhushana, A. et al. Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant. BMC Cell Biol. 11, 4 (2010).","journal-title":"BMC Cell Biol."},{"key":"8534_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1126\/science.aaf6803","volume":"353","author":"Y Ito","year":"2016","unstructured":"Ito, Y. et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353, 603\u2013608 (2016).","journal-title":"Science"},{"key":"8534_CR15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.febslet.2008.02.047","volume":"582","author":"S Morton","year":"2008","unstructured":"Morton, S., Hesson, L., Peggie, M. & Cohen, P. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 582, 997\u20131002 (2008).","journal-title":"FEBS Lett."},{"key":"8534_CR16","first-page":"3314","volume":"17","author":"H Li","year":"2011","unstructured":"Li, H., Ao, X., Jia, J., Wang, Q. & Zhang, Z. Effects of optineurin siRNA on apoptotic genes and apoptosis in RGC-5 cells. Mol. Vis. 17, 3314\u20133325 (2011).","journal-title":"Mol. Vis."},{"key":"8534_CR17","doi-asserted-by":"publisher","first-page":"8593","DOI":"10.1523\/JNEUROSCI.4488-06.2007","volume":"27","author":"JT Wang","year":"2007","unstructured":"Wang, J. T. et al. Disease gene candidates revealed by expression profiling of retinal ganglion cell development.  J. Neurosci. 27, 8593 (2007).","journal-title":"J. Neurosci."},{"key":"8534_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00417-003-0702-0","volume":"241","author":"N Kiriyama","year":"2003","unstructured":"Kiriyama, N. et al. A comparison of optic disc topographic parameters in patients with primary open angle glaucoma, normal tension glaucoma, and ocular hypertension. Graefe\u2019s. Arch. Clin. Exp. Ophthalmol. 241, 541\u2013545 (2003).","journal-title":"Graefe\u2019s. Arch. Clin. Exp. Ophthalmol."},{"key":"8534_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/IJG.0b013e318193c45c","volume":"19","author":"O Thonginnetra","year":"2010","unstructured":"Thonginnetra, O. et al. Normal versus high tension glaucoma: a comparison of functional and structural defects. J. Glaucoma 19, 151\u2013157 (2010).","journal-title":"J. Glaucoma"},{"key":"8534_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3892\/mmr.2024.13207","volume":"29","author":"Q Xia","year":"2024","unstructured":"Xia, Q. & Zhang, D. Apoptosis in glaucoma: a new direction for the treatment of glaucoma (Review). Mol. Med Rep. 29, 82 (2024).","journal-title":"Mol. Med Rep."},{"key":"8534_CR21","first-page":"563","volume":"17","author":"A Trivli","year":"2019","unstructured":"Trivli, A. et al. Normal\u2011tension glaucoma: pathogenesis and genetics (review). Exp. Ther. Med 17, 563\u2013574 (2019).","journal-title":"Exp. Ther. Med"},{"key":"8534_CR22","doi-asserted-by":"publisher","first-page":"107920","DOI":"10.1016\/j.exer.2020.107920","volume":"191","author":"H Hernandez","year":"2020","unstructured":"Hernandez, H., Roberts, A. L. & McDowell, C. M. Nuclear factor-kappa beta signaling is required for transforming growth factor Beta-2 induced ocular hypertension. Exp. Eye Res. 191, 107920 (2020).","journal-title":"Exp. Eye Res."},{"key":"8534_CR23","first-page":"3260","volume":"56","author":"G Zode","year":"2015","unstructured":"Zode, G. Increased endoplasmic reticulum stress in human glaucomatous trabecular meshwork cells and tissues. Investig. Ophthalmol. Vis. Sci. 56, 3260\u20133260 (2015).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"8534_CR24","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/febs.16739","volume":"290","author":"Z Sayyad","year":"2023","unstructured":"Sayyad, Z. et al. A glaucoma-associated OPTN polymorphism, M98K sensitizes retinal cells to endoplasmic reticulum stress and tumour necrosis factor \u03b1.  FEBS J. 290, 3110\u20133127 (2023).","journal-title":"FEBS J."},{"key":"8534_CR25","first-page":"1563","volume":"9","author":"XS Mi","year":"2014","unstructured":"Mi, X. S., Yuan, T. F. & So, K. F. The current research status of normal tension glaucoma. Clin. Inter. Aging 9, 1563\u20131571 (2014).","journal-title":"Clin. Inter. Aging"},{"key":"8534_CR26","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Berm\u00fadez, M. Y. et al. Glial cells in glaucoma: friends, foes, and potential therapeutic targets. Front. Neurol. 12 (2021).","DOI":"10.3389\/fneur.2021.624983"},{"key":"8534_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbrc.2020.11.091","volume":"534","author":"G Ramachandran","year":"2021","unstructured":"Ramachandran, G., Moharir, S. C., Raghunand, T. R. & Swarup, G. Optineurin modulates ER stress-induced signaling pathways and cell death. Biochem. Biophys. Res. Commun. 534, 297\u2013302 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"8534_CR28","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.ophtha.2007.04.003","volume":"114","author":"B Nemesure","year":"2007","unstructured":"Nemesure, B., Honkanen, R., Hennis, A., Wu, S. Y. & Leske, M. C. Incident open-angle glaucoma and intraocular pressure. Ophthalmology 114, 1810\u20131815 (2007).","journal-title":"Ophthalmology"},{"key":"8534_CR29","doi-asserted-by":"crossref","unstructured":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am. J. Ophthalmol. 126, 487\u2013497 (1998).","DOI":"10.1016\/S0002-9394(98)00223-2"},{"key":"8534_CR30","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl, A. et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch. Ophthalmol. 120, 1268\u20131279 (2002).","journal-title":"Arch. Ophthalmol."},{"key":"8534_CR31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.survophthal.2021.12.003","volume":"67","author":"WS Shalaby","year":"2022","unstructured":"Shalaby, W. S., Ahmed, O. M., Waisbourd, M. & Katz, L. J. A review of potential novel glaucoma therapeutic options independent of intraocular pressure. Surv. Ophthalmol. 67, 1062\u20131080 (2022).","journal-title":"Surv. Ophthalmol."},{"key":"8534_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100998","volume":"87","author":"G Tezel","year":"2022","unstructured":"Tezel, G. Molecular regulation of neuroinflammation in glaucoma: current knowledge and the ongoing search for new treatment targets. Prog. Retinal Eye Res. 87, 100998 (2022).","journal-title":"Prog. Retinal Eye Res."},{"key":"8534_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s40135-019-00212-1","volume":"7","author":"M Bari\u015f","year":"2019","unstructured":"Bari\u015f, M. & Tezel, G. Immunomodulation as a neuroprotective strategy for glaucoma treatment. Curr. Ophthalmol. Rep. 7, 160\u2013169 (2019).","journal-title":"Curr. Ophthalmol. Rep."},{"key":"8534_CR34","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.preteyeres.2020.100916","volume":"83","author":"C Baudouin","year":"2021","unstructured":"Baudouin, C., Kolko, M., Melik-Parsadaniantz, S. & Messmer, E. M. Inflammation in Glaucoma: from the back to the front of the eye, and beyond. Prog. Retinal Eye Res. 83, 100916 (2021).","journal-title":"Prog. Retinal Eye Res."},{"key":"8534_CR35","doi-asserted-by":"publisher","first-page":"112889","DOI":"10.1016\/j.celrep.2023.112889","volume":"42","author":"L Pan","year":"2023","unstructured":"Pan, L. et al. IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy. Cell Rep. 42, 112889 (2023).","journal-title":"Cell Rep."},{"key":"8534_CR36","doi-asserted-by":"publisher","first-page":"107776","DOI":"10.1016\/j.celrep.2020.107776","volume":"31","author":"KA Guttenplan","year":"2020","unstructured":"Guttenplan, K. A. et al. Neurotoxic reactive astrocytes drive neuronal death after retinal injury. Cell Rep. 31, 107776 (2020).","journal-title":"Cell Rep."},{"key":"8534_CR37","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/cells10061339","volume":"10","author":"H-S Yoo","year":"2021","unstructured":"Yoo, H.-S., Shanmugalingam, U. & Smith, P. D. Harnessing astrocytes and m\u00fcller glial cells in the retina for survival and regeneration of retinal ganglion cells. Cells 10, 1339 (2021).","journal-title":"Cells"},{"key":"8534_CR38","doi-asserted-by":"publisher","first-page":"804782","DOI":"10.3389\/fncel.2022.804782","volume":"16","author":"L Guo","year":"2022","unstructured":"Guo, L., Choi, S., Bikkannavar, P. & Cordeiro, M. F. Microglia: key players in retinal ageing and neurodegeneration. Front. Cell. Neurosci. 16, 804782 (2022).","journal-title":"Front. Cell. Neurosci."},{"key":"8534_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1242\/dmm.018788","volume":"8","author":"A Bosco","year":"2015","unstructured":"Bosco, A. et al. Neurodegeneration severity can be predicted from early microglia alterations monitored in vivo in a mouse model of chronic glaucoma. Dis. Models Mech. 8, 443\u2013455 (2015).","journal-title":"Dis. Models Mech."},{"key":"8534_CR40","doi-asserted-by":"publisher","first-page":"e67094","DOI":"10.1371\/journal.pone.0067094","volume":"8","author":"J Qu","year":"2013","unstructured":"Qu, J. & Jakobs, T. C. The time course of gene expression during reactive gliosis in the optic nerve. PLOS ONE 8, e67094 (2013).","journal-title":"PLOS ONE"},{"key":"8534_CR41","doi-asserted-by":"publisher","first-page":"1132011","DOI":"10.3389\/fopht.2023.1132011","volume":"3","author":"M Ishikawa","year":"2023","unstructured":"Ishikawa, M. et al. Glaucoma and microglia-induced neuroinflammation. Front. Ophthalmol. 3, 1132011 (2023).","journal-title":"Front. Ophthalmol."},{"key":"8534_CR42","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.neuron.2022.06.003","volume":"110","author":"F Tian","year":"2022","unstructured":"Tian, F. et al. Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells. Neuron 110, 2607\u20132624.e2608 (2022).","journal-title":"Neuron"},{"key":"8534_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0214-8","volume":"12","author":"SB Syc-Mazurek","year":"2017","unstructured":"Syc-Mazurek, S. B., Fernandes, K. A., Wilson, M. P., Shrager, P. & Libby, R. T. Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury. Mol. Neurodegen. 12, 71 (2017).","journal-title":"Mol. Neurodegen."},{"key":"8534_CR44","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.omtn.2023.07.015","volume":"33","author":"F Fang","year":"2023","unstructured":"Fang, F. et al. RGC-specific ATF4 and\/or CHOP deletion rescues glaucomatous neurodegeneration and visual function. Mol. Ther. Nucleic Acids 33, 286\u2013295 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"8534_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/0271678X231171999","volume":"43","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. The multifaceted roles of activating transcription factor 3 (ATF3) in inflammatory responses\u2014potential target to regulate neuroinflammation in acute brain injury. J. Cereb. Blood Flow. Metab. 43, 8\u201317 (2023).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"8534_CR46","doi-asserted-by":"publisher","first-page":"17698","DOI":"10.1073\/pnas.1011736107","volume":"107","author":"JC Goodall","year":"2010","unstructured":"Goodall, J. C. et al. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc. Natl. Acad. Sci. USA 107, 17698\u201317703 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8534_CR47","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1091\/mbc.E15-01-0036","volume":"26","author":"JA Willy","year":"2015","unstructured":"Willy, J. A., Young, S. K., Stevens, J. L., Masuoka, H. C. & Wek, R. C. CHOP links endoplasmic reticulum stress to NF-\u03baB activation in the pathogenesis of nonalcoholic steatohepatitis. Mol. Biol. Cell 26, 2190\u20132204 (2015).","journal-title":"Mol. Biol. Cell"},{"key":"8534_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2021.125997","volume":"417","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Microglia-derived IL-1\u03b2 promoted neuronal apoptosis through ER stress-mediated signaling pathway PERK\/eIF2\u03b1\/ATF4\/CHOP upon arsenic exposure. J. Hazard. Mater. 417, 125997 (2021).","journal-title":"J. Hazard. Mater."},{"key":"8534_CR49","doi-asserted-by":"publisher","first-page":"612422","DOI":"10.3389\/fneur.2020.612422","volume":"11","author":"T Rolle","year":"2021","unstructured":"Rolle, T., Ponzetto, A. & Malinverni, L. The role of neuroinflammation in glaucoma: an update on molecular mechanisms and new therapeutic options. Front. Neurol. 11, 612422 (2021).","journal-title":"Front. Neurol."},{"key":"8534_CR50","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/ijms23010386","volume":"23","author":"G Kaur","year":"2022","unstructured":"Kaur, G. & Singh, N. K. The role of inflammation in retinal neurodegeneration and degenerative diseases. Int. J. Mol. Sci. 23, 386 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"8534_CR51","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.4049\/jimmunol.1301696","volume":"191","author":"I Munitic","year":"2013","unstructured":"Munitic, I. et al. Optineurin insufficiency impairs IRF3 but Not NF-\u03baB activation in immune cells.  J. Immunol. 191, 6231\u20136240 (2013).","journal-title":"J. Immunol."},{"key":"8534_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57135-8","volume":"16","author":"D Liu","year":"2025","unstructured":"Liu, D. et al. Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration. Nat. Commun. 16, 1789 (2025).","journal-title":"Nat. Commun."},{"key":"8534_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1625-y","volume":"16","author":"J Augustine","year":"2019","unstructured":"Augustine, J. et al. IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment. J. Neuroinflamm. 16, 251 (2019).","journal-title":"J. Neuroinflamm."},{"key":"8534_CR54","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/imm.13479","volume":"166","author":"W Fan","year":"2022","unstructured":"Fan, W. et al. Retinal microglia: functions and diseases. Immunology 166, 268\u2013286 (2022).","journal-title":"Immunology"},{"key":"8534_CR55","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","volume":"49","author":"R Fu","year":"2014","unstructured":"Fu, R., Shen, Q., Xu, P., Luo, J. J. & Tang, Y. Phagocytosis of microglia in the central nervous system diseases. Mol. Neurobiol. 49, 1422\u20131434 (2014).","journal-title":"Mol. Neurobiol."},{"key":"8534_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19351-w","volume":"12","author":"A Kumari","year":"2022","unstructured":"Kumari, A. et al. Single cell RNA sequencing confirms retinal microglia activation associated with early onset retinal degeneration. Sci. Rep. 12, 15273 (2022).","journal-title":"Sci. Rep."},{"key":"8534_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.61.8.15","volume":"61","author":"VL Bonilha","year":"2020","unstructured":"Bonilha, V. L. et al. Geographic atrophy: confocal scanning laser ophthalmoscopy, histology, and inflammation in the region of expanding lesions. Investig. Ophthalmol. Vis. Sci. 61, 15\u201315 (2020).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"8534_CR58","doi-asserted-by":"crossref","unstructured":"Hong, E. et al. Biologically driven in vivo occlusion design provides a reliable experimental glaucoma model. bioRxiv, 2024.2001.2018.576306 (2024).","DOI":"10.1101\/2024.01.18.576306"},{"key":"8534_CR59","doi-asserted-by":"publisher","first-page":"327326","DOI":"10.1155\/2012\/327326","volume":"2012","author":"M Iester","year":"2012","unstructured":"Iester, M., De Feo, F. & Douglas, G. R. Visual field loss morphology in high- and normal-tension glaucoma. J. Ophthalmol. 2012, 327326 (2012).","journal-title":"J. Ophthalmol."},{"key":"8534_CR60","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.neuron.2019.11.006","volume":"104","author":"NM Tran","year":"2019","unstructured":"Tran, N. M. et al. Single-cell profiles of retinal ganglion cells differing in resilience to injury reveal neuroprotective genes. Neuron 104, 1039\u20131055.e1012 (2019).","journal-title":"Neuron"},{"key":"8534_CR61","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.neuron.2015.02.017","volume":"85","author":"X Duan","year":"2015","unstructured":"Duan, X. et al. Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling. Neuron 85, 1244\u20131256 (2015).","journal-title":"Neuron"},{"key":"8534_CR62","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acschemneuro.0c00757","volume":"12","author":"DC Sarver","year":"2021","unstructured":"Sarver, D. C., Lei, X. & Wong, G. W. FAM19A (TAFA): an emerging family of neurokines with diverse functions in the central and peripheral nervous system. ACS Chem. Neurosci. 12, 945\u2013958 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"8534_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1523\/JNEUROSCI.2599-16.2016","volume":"37","author":"Q Li","year":"2017","unstructured":"Li, Q., Bartley, A. F. & Dobrunz, L. E. Endogenously released neuropeptide y suppresses hippocampal short-term facilitation and is impaired by stress-induced anxiety.  J. Neurosci. 37, 23 (2017).","journal-title":"J. Neurosci."},{"key":"8534_CR64","doi-asserted-by":"publisher","first-page":"17125","DOI":"10.1073\/pnas.012481899","volume":"99","author":"A Bacci","year":"2002","unstructured":"Bacci, A., Huguenard, J. R. & Prince, D. A. Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons. Proc. Natl. Acad. Sci. USA 99, 17125\u201317130 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8534_CR65","doi-asserted-by":"publisher","first-page":"pgae299","DOI":"10.1093\/pnasnexus\/pgae299","volume":"3","author":"V Palanivel","year":"2024","unstructured":"Palanivel, V. et al. Neuropeptide Y receptor activation preserves inner retinal integrity through PI3K\/Akt signaling in a glaucoma mouse model. PNAS Nexus 3, pgae299 (2024).","journal-title":"PNAS Nexus"},{"key":"8534_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100142","volume":"2","author":"M Daniszewski","year":"2022","unstructured":"Daniszewski, M. et al. Retinal ganglion cell-specific genetic regulation in primary open-angle glaucoma. Cell Genomics 2, 100142 (2022).","journal-title":"Cell Genomics"},{"key":"8534_CR67","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41551-022-00938-7","volume":"6","author":"Y Yao","year":"2022","unstructured":"Yao, Y. et al. Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood\u2013brain barrier in rodents and primates. Nat. Biomed. Eng. 6, 1257\u20131271 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"8534_CR68","doi-asserted-by":"publisher","first-page":"101269","DOI":"10.1016\/j.omtm.2024.101269","volume":"32","author":"ML Sangster","year":"2024","unstructured":"Sangster, M. L. et al. A blood-brain barrier-penetrant AAV gene therapy improves neurological function in symptomatic mucolipidosis IV mice. Mol. Ther. Methods Clin. Dev. 32, 101269 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"8534_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/srep33830","volume":"6","author":"MS Shim","year":"2016","unstructured":"Shim, M. S. et al. Mitochondrial pathogenic mechanism and degradation in optineurin E50K mutation-mediated retinal ganglion cell degeneration. Sci. Rep. 6, 33830 (2016).","journal-title":"Sci. Rep."},{"key":"8534_CR70","first-page":"2385","volume":"62","author":"V Adi","year":"2021","unstructured":"Adi, V. et al. Longitudinal age effects of optineurin E50K mutation and deficiency on visual function. Investig. Ophthalmol. Vis. Sci. 62, 2385\u20132385 (2021).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"8534_CR71","doi-asserted-by":"publisher","first-page":"e0138289","DOI":"10.1371\/journal.pone.0138289","volume":"10","author":"K Sirohi","year":"2015","unstructured":"Sirohi, K., Kumari, A., Radha, V. & Swarup, G. A glaucoma-associated variant of optineurin, M98K, activates Tbk1 to enhance autophagosome formation and retinal cell death dependent on Ser177 phosphorylation of optineurin. PLOS ONE 10, e0138289 (2015).","journal-title":"PLOS ONE"},{"key":"8534_CR72","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1093\/hmg\/ddt210","volume":"22","author":"Y Minegishi","year":"2013","unstructured":"Minegishi, Y. et al. Enhanced optineurin E50K\u2013TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma. Hum. Mol. Genet. 22, 3559\u20133567 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"8534_CR73","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3389\/fimmu.2018.01017","volume":"9","author":"RP Toth","year":"2018","unstructured":"Toth, R. P. & Atkin, J. D. Dysfunction of optineurin in amyotrophic lateral sclerosis and glaucoma. Front. Immunol. 9, 1017 (2018).","journal-title":"Front. Immunol."},{"key":"8534_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuron.2019.04.033","volume":"103","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Elevating growth factor responsiveness and axon regeneration by modulating presynaptic inputs. Neuron 103, 39\u201351.e35 (2019).","journal-title":"Neuron"},{"key":"8534_CR75","doi-asserted-by":"publisher","first-page":"108463","DOI":"10.1016\/j.visres.2024.108463","volume":"224","author":"C-C Su","year":"2024","unstructured":"Su, C.-C., Liu, C., Adi, V., Chan, K. C. & Tseng, H. C. Age-related effects of optineurin deficiency in the mouse eye. Vis. Res. 224, 108463 (2024).","journal-title":"Vis. Res."},{"key":"8534_CR76","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1212\/WNL.0000000000002334","volume":"86","author":"O Goldstein","year":"2016","unstructured":"Goldstein, O. et al. OPTN 691_692insAG is a founder mutation causing recessive ALS and increased risk in heterozygotes. Neurology 86, 446\u2013453 (2016).","journal-title":"Neurology"},{"key":"8534_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12708","volume":"7","author":"F Li","year":"2016","unstructured":"Li, F. et al. Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins. Nat. Commun. 7, 12708 (2016).","journal-title":"Nat. Commun."},{"key":"8534_CR78","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease.  Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"8534_CR79","doi-asserted-by":"publisher","first-page":"e0175882","DOI":"10.1371\/journal.pone.0175882","volume":"12","author":"S Pierce","year":"2017","unstructured":"Pierce, S. & Coetzee, G. A. Parkinson\u2019s disease-associated genetic variation is linked to quantitative expression of inflammatory genes. PLOS ONE 12, e0175882 (2017).","journal-title":"PLOS ONE"},{"key":"8534_CR80","doi-asserted-by":"crossref","unstructured":"Silvestroni, A., Faull, R. L. M., Strand, A. D. & M\u00f6ller, T. Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease. NeuroReport 20 (2009).","DOI":"10.1097\/WNR.0b013e32832e34ee"},{"key":"8534_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0896-4","volume":"14","author":"JH Jara","year":"2017","unstructured":"Jara, J. H. et al. Evidence for an early innate immune response in the motor cortex of ALS. J. Neuroinflammation 14, 129 (2017).","journal-title":"J. Neuroinflammation"},{"key":"8534_CR82","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.3390\/jcm9103172","volume":"9","author":"S Vernazza","year":"2020","unstructured":"Vernazza, S., Tirendi, S., Bassi, A. M., Traverso, C. E. & Sacc\u00e0, S. C. Neuroinflammation in primary open-angle glaucoma. J. Clin. Med. 9, 3172 (2020).","journal-title":"J. Clin. Med."},{"key":"8534_CR83","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/1073858403253460","volume":"9","author":"AH Neufeld","year":"2003","unstructured":"Neufeld, A. H. & Liu, B. Glaucomatous optic neuropathy: when glia misbehave.  Neuroscientist 9, 485\u2013495 (2003).","journal-title":"Neuroscientist"},{"key":"8534_CR84","doi-asserted-by":"publisher","first-page":"a017269","DOI":"10.1101\/cshperspect.a017269","volume":"4","author":"I Soto","year":"2014","unstructured":"Soto, I. & Howell, G. R. The complex role of neuroinflammation in glaucoma. Cold Spring Harb. Perspect. Med 4, a017269 (2014).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"8534_CR85","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1167\/iovs.07-1337","volume":"49","author":"A Bosco","year":"2008","unstructured":"Bosco, A. et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA\/2J mouse model of glaucoma. Investig. Ophthalmol. Vis. Sci. 49, 1437\u20131446 (2008).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"8534_CR86","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neuron.2020.07.026","volume":"108","author":"W Renthal","year":"2020","unstructured":"Renthal, W. et al. Transcriptional reprogramming of distinct peripheral sensory neuron subtypes after axonal injury. Neuron 108, 128\u2013144.e129 (2020).","journal-title":"Neuron"},{"key":"8534_CR87","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.neuron.2022.06.002","volume":"110","author":"A Jacobi","year":"2022","unstructured":"Jacobi, A. et al. Overlapping transcriptional programs promote survival and axonal regeneration of injured retinal ganglion cells. Neuron 110, 2625\u20132645.e2627 (2022).","journal-title":"Neuron"},{"key":"8534_CR88","first-page":"589589","volume":"2012","author":"G Jing","year":"2012","unstructured":"Jing, G., Wang, J. J. & Zhang, S. X. ER stress and apoptosis: a new mechanism for retinal cell death. J. Diab Res. 2012, 589589 (2012).","journal-title":"J. Diab Res."},{"key":"8534_CR89","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.3390\/cells11223665","volume":"11","author":"V Palanivel","year":"2022","unstructured":"Palanivel, V. et al. Neuroprotective effects of neuropeptide Y on human neuroblastoma SH-SY5Y cells in glutamate excitotoxicity and ER stress conditions. Cells 11, 3665 (2022).","journal-title":"Cells"},{"key":"8534_CR90","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejcb.2018.04.003","volume":"97","author":"DY Lee","year":"2018","unstructured":"Lee, D. Y. et al. Neuropeptide Y mitigates ER stress\u2013induced neuronal cell death by activating the PI3K\u2013XBP1 pathway. Eur. J. Cell Biol. 97, 339\u2013348 (2018).","journal-title":"Eur. J. Cell Biol."},{"key":"8534_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.160","volume":"4","author":"A Santos-Carvalho","year":"2013","unstructured":"Santos-Carvalho, A., Elvas, F., Alvaro, A. R., Ambrosio, A. F. & Cavadas, C. Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate. Cell Death Dis. 4, e636 (2013).","journal-title":"Cell Death Dis."},{"key":"8534_CR92","doi-asserted-by":"crossref","unstructured":"Palanivel, V., Basavarajappa, D., Gupta, V. & Graham, S. Protective effects of neuropeptide Y treatment on retina in a mouse model of experimental glaucoma. Acta Ophthalmol. 102 (2024).","DOI":"10.1111\/aos.16228"},{"key":"8534_CR93","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/nu14030534","volume":"14","author":"RH Sim","year":"2022","unstructured":"Sim, R. H., Sirasanagandla, S. R., Das, S. & Teoh, S. L. Treatment of glaucoma with natural products and their mechanism of action: an update. Nutrients 14, 534 (2022).","journal-title":"Nutrients"},{"key":"8534_CR94","doi-asserted-by":"publisher","first-page":"12633","DOI":"10.1523\/JNEUROSCI.2801-06.2006","volume":"26","author":"T Nakazawa","year":"2006","unstructured":"Nakazawa, T. et al. Tumor necrosis factor-\u03b1 mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma.  J. Neurosci. 26, 12633 (2006).","journal-title":"J. Neurosci."},{"key":"8534_CR95","doi-asserted-by":"publisher","first-page":"e40065","DOI":"10.1371\/journal.pone.0040065","volume":"7","author":"M Roh","year":"2012","unstructured":"Roh, M. et al. Etanercept, a widely used inhibitor of tumor necrosis factor-\u03b1 (TNF- \u03b1), prevents retinal ganglion cell loss in a rat model of glaucoma. PLOS ONE 7, e40065 (2012).","journal-title":"PLOS ONE"},{"key":"8534_CR96","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","volume":"187","author":"M Kitazawa","year":"2011","unstructured":"Kitazawa, M. et al. Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model.  J. Immunol. 187, 6539\u20136549 (2011).","journal-title":"J. Immunol."},{"key":"8534_CR97","first-page":"305","volume":"1","author":"MT Mizwicki","year":"2012","unstructured":"Mizwicki, M. T. et al. Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling. Am. J. Neurodegener. Dis. 1, 305\u2013315 (2012).","journal-title":"Am. J. Neurodegener. Dis."},{"key":"8534_CR98","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archneur.2008.65.7.nct70006","volume":"65","author":"Group*, A. R.","year":"2008","unstructured":"Group*, A. R. Cognitive Function Over Time in the Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib. Arch. Neurol. 65, 896\u2013905 (2008).","journal-title":"Arch. Neurol."},{"key":"8534_CR99","unstructured":"K\u00fcchlin, S. et al. Treatment with erythropoietin for patients with optic neuritis. Neurol. Neuroimmunol. Neuroinflammation 10, e200067."},{"key":"8534_CR100","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/eye.2012.296","volume":"27","author":"DB Rootman","year":"2013","unstructured":"Rootman, D. B., Gill, H. S. & Margolin, E. A. Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial. Eye 27, 538\u2013544 (2013).","journal-title":"Eye"},{"key":"8534_CR101","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3390\/jcm13030887","volume":"13","author":"A Ahmadzadeh","year":"2024","unstructured":"Ahmadzadeh, A., Kessel, L., Schmidt, B. S., Kolko, M. & Bach-Holm, D. Steroids and\/or non-steroidal anti-inflammatory drugs as postoperative treatment after trabeculectomy\u201412-month results of a randomized controlled trial. J. Clin. Med. 13, 887 (2024).","journal-title":"J. Clin. Med."},{"key":"8534_CR102","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/ijnp\/pyaa054","volume":"23","author":"AA Math\u00e9","year":"2020","unstructured":"Math\u00e9, A. A., Michaneck, M., Berg, E., Charney, D. S. & Murrough, J. W. A randomized controlled trial of intranasal neuropeptide Y in patients with major depressive disorder. Int. J. Neuropsychopharmacol. 23, 783\u2013790 (2020).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"8534_CR103","doi-asserted-by":"publisher","first-page":"106699","DOI":"10.1016\/j.dib.2020.106699","volume":"34","author":"J Arcuri","year":"2021","unstructured":"Arcuri, J., Hegarty, S., He, Z. & Bhattacharya, S. K. Lipidomics dataset of PTEN deletion-induced optic nerve regeneration mouse model. Data Brief. 34, 106699 (2021).","journal-title":"Data Brief."},{"key":"8534_CR104","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.neuron.2015.10.005","volume":"88","author":"H Nawabi","year":"2015","unstructured":"Nawabi, H. et al. Doublecortin-like kinases promote neuronal survival and induce growth cone reformation via distinct mechanisms. Neuron 88, 704\u2013719 (2015).","journal-title":"Neuron"},{"key":"8534_CR105","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.neuron.2017.05.035","volume":"94","author":"MW Norsworthy","year":"2017","unstructured":"Norsworthy, M. W. et al. Sox11 expression promotes regeneration of some retinal ganglion cell types but kills others. Neuron 94, 1112\u20131120.e1114 (2017).","journal-title":"Neuron"},{"key":"8534_CR106","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1167\/iovs.12-9814","volume":"53","author":"Q Yang","year":"2012","unstructured":"Yang, Q. et al. Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma. Investig. Ophthalmol. Vis. Sci. 53, 3733\u20133741 (2012).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"8534_CR107","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"8534_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08534-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08534-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08534-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:05:48Z","timestamp":1760627148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08534-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8534"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08534-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.T. and D.J. are co-founders of Regenerative AI LLC. F.B. is a founder of and scientific advisor to Brave Bio Inc. F.B. is an inventor of AAV.CPP.16 used in this study. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1475"}}